Therapeutic Drug Monitoring

Therapeutic drug monitoring (TDM) is the measurement of drug concentrations in blood or other fluids to guide dosing of medicines whose useful range is narrow. It is applied when the link between dose and effect is unreliable but the link between concentration and effect is stronger, so that measuring exposure helps keep a patient within a band where the drug is likely to be effective without being toxic.

Definition

Therapeutic drug monitoring is the clinical practice of measuring drug concentrations in biological fluids and using them, together with patient and clinical information, to individualise dosing of agents that have a narrow therapeutic window or highly variable handling.

Scope

The topic covers which drugs are candidates for monitoring, the concept of a target concentration range, the timing of sampling relative to dosing, and the interpretation of measured concentrations alongside clinical response. It is a reference topic describing the rationale and logic of monitoring and does not provide target values, sampling protocols, or dose-adjustment instructions for any patient.

Core questions

• Which drugs warrant concentration monitoring, and why?
• What is a therapeutic range, and how does it relate to effect and toxicity?
• When should a sample be taken relative to dosing for the result to be interpretable?
• How are measured concentrations interpreted alongside clinical response?
• How does measured exposure connect to underlying variability in drug handling?

Key concepts

• Narrow therapeutic window
• Therapeutic (target) concentration range
• Concentration-effect relationship
• Trough, peak, and steady-state sampling
• Sampling timing and interpretation
• Exposure-driven dose individualisation
• Pharmacokinetic variability

Mechanisms

Monitoring is useful when a drug shows a close and reproducible relationship between concentration and effect but an unreliable relationship between dose and concentration, because patients vary in absorption, distribution, metabolism, and elimination. For such drugs a target concentration range is defined within which benefit is likely and toxicity is less likely. A concentration is measured at a defined time relative to dosing - commonly at steady state and often as a trough - so that the value can be compared against the target and interpreted in light of the patient's clinical response. The measured exposure then informs whether and how the regimen should be reconsidered, always alongside clinical judgement rather than in isolation.

Clinical relevance

TDM is a routine tool of clinical pharmacy for selected drugs, linking measured exposure to dosing decisions and to the underlying variability the patient brings. As a reference topic it explains why and when concentration measurement is informative; it describes the logic of monitoring and is not a source of target ranges, sampling instructions, or individualised dosing advice.

Epidemiology

Monitoring is reserved for a defined set of agents - classically certain antimicrobials, immunosuppressants, anticonvulsants, and a few others - for which narrow margins, serious toxicity, or marked pharmacokinetic variability make concentration measurement worthwhile rather than for medicines in general.

Evidence & guidelines

Drug-specific consensus guidelines define how monitoring should be approached for particular agents; for example, revised consensus guidance addresses concentration- and exposure-based monitoring of vancomycin for serious resistant staphylococcal infection. Such guidelines anchor the targets and sampling logic used in practice.

History

As assays capable of measuring drug concentrations became available in the later twentieth century, clinicians recognised that for certain narrow-margin drugs measured exposure predicted outcome better than dose alone. Monitoring became established for those agents, and the approach has since evolved toward exposure-based targets supported by pharmacokinetic reasoning.

Debates

Concentration targets versus exposure (AUC) targets

For some monitored drugs there is debate over whether a single concentration (such as a trough) or an integrated exposure measure better predicts efficacy and toxicity; vancomycin monitoring guidance, for instance, has shifted toward exposure-based targets.

Seminal works

• rybak-2020
• wilkinson-2005

Frequently asked questions

Why are only some drugs monitored by concentration?

Monitoring helps mainly for drugs with a narrow therapeutic window or unpredictable handling, where the concentration predicts effect better than the dose does; for most medicines, clinical response alone is a sufficient guide.

Why does the timing of the blood sample matter?

Drug concentrations change over the dosing interval, so a result is only interpretable when the sample is taken at a defined time - often at steady state and frequently as a trough - relative to the dose.